VPAResearch: Market Research Reports

... Over 20 companies and universities are focusing on developing treatment options for Peptic Ulcers. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peptic Ulcers pipeline product. Mechanism ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peritonitis pipeline product. Mechanism of Action and ...

... companies and universities are focusing on developing treatment options for Post Operative Nausea and Vomiting. To assist investigators and funding and regulatory ... , VPA Research has come up with a comprehensive report on Post Operative Nausea and Vomiting pipeline. The report provides insights into different ...

... and universities are focusing on developing treatment options for Primary biliary cirrhosis. To assist investigators and funding and regulatory organizations, ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary biliary cirrhosis pipeline product. Mechanism ...

... universities are focusing on developing treatment options for Primary billary cholangitis. To assist investigators and funding and regulatory organizations ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary billary cholangitis pipeline product. Mechanism ...

... universities are focusing on developing treatment options for Primary sclerosing cholangitis. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Primary sclerosing cholangitis pipeline product. Mechanism ...

... Around 30 companies and universities are focusing on developing treatment options for Reflux Esophagitis/GERD. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Reflux Esophagitis/GERD pipeline product. ...

... and universities are focusing on developing treatment options for Short Bowel Syndrome. To assist investigators and funding and regulatory organizations, ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Short Bowel Syndrome pipeline product. Mechanism of ...

... Around 15 companies and universities are focusing on developing treatment options for Systemic Mastocytosis. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Systemic Mastocytosis pipeline product. ...

... Around 10 companies and universities are focusing on developing treatment options for Traveler's Diarrhea. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Traveler's Diarrhea pipeline product. ...

... and universities are focusing on developing treatment options for Alcoholic Hepatitis. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Alcoholic Hepatitis pipeline product. ...

... and universities are focusing on developing treatment options for Atrial Fibrillation. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Atrial Fibrillation pipeline product. ...

... , neurological conditions. Celiac Disease pipeline comprises of 24 active drugs under active development as of April 2018. Of these, 4 drugs are in Phase 1 and 4 drugs in phase 2. None of the drugs have progressed ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Colitis pipeline product. Mechanism of Action and ...

... myalgia, arthralgia are key symptoms. Community Acquired Pneumonia pipeline comprises of 16 drugs under active development as of April 2018. Of these, 3 drugs are ... has come up with a comprehensive report on Community Acquired Pneumonia (CAP) pipeline. The report provides insights into different therapeutic ...

... Critical Limb Ischemia worldwide, with an estimated market size of $10 to $12 billion. Critical Limb Ischemia pipeline comprises of 27 active drugs under active development as of April 2018 ... come up with a comprehensive report on Critical Limb Ischemia (CLI) pipeline. The report provides insights into ...

... no vaccine is available against HCV. Due to the mutations in Hepatitis C virus, development of a prophylactic vaccine is highly challenging. The condition is classified ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatitis C (HCV) pipeline ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Pre-eclampsia pipeline product. Mechanism of Action and ...

... scalp are affected areas. Trigeminal Neuralgia pipeline comprises of 9 active drugs under active development as of April 2018. Of these, 4 drugs are in phase 2. Further, 4 drugs are in Pre-clinical stage ...

... pipeline review “Pulmonary Arterial Hypertension (PAH)- Drug Development Pipeline Study” provides in-depth analysis and update information on Pulmonary Arterial Hypertension (PAH) pipeline drugs. Current status of all the drugs in the Pulmonary Arterial Hypertension (PAH) pipeline ...

... . The most comprehensive pipeline review “Resistant Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Resistant Hypertension pipeline drugs. Current status of all the drugs in the Resistant Hypertension pipeline is provided in the ...

... . The most comprehensive pipeline review “Portal Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Portal Hypertension pipeline drugs. Current status of all the drugs in the Portal Hypertension pipeline is provided in the ...

... . The most comprehensive pipeline review “Ocular Hypertension- Drug Development Pipeline Study” provides in-depth analysis and update information on Ocular Hypertension pipeline drugs. Current status of all the drugs in the Ocular Hypertension pipeline is provided in the ...

... . The most comprehensive pipeline review “Cancer Cachexia- Drug Development Pipeline Study” provides in-depth analysis and update information on Cancer Cachexia pipeline drugs. Current status of all the drugs in the Cancer Cachexia pipeline is provided in the ...

... that impact the Hypoparathyroidism industry. Excerpts from- “Hypoparathyroidism- Drug Development Pipeline Study”: Hypoparathyroidism pipeline comprises of 6 drugs under development as of February 2018. Of these, 3 drugs are in Phase 1 and 1 drug is in phase 2. Further, 2 drugs remain in Pre ...

... the Impetigo industry. Excerpts from- “Impetigo- Drug Development Pipeline Study”: Impetigo pipeline comprises of 4 drugs under development as of February 2018. Of these, 2 drugs are in Phase 2 and 1 drug is in phase 2/3. Further, 1 drug is in Pre-Clinical Stage. No drugs have ...

... Diffuse Intrinsic Pontine Glioma (DIPG) industry. Excerpts from- “Diffuse Intrinsic Pontine Glioma (DIPG)- Drug Development Pipeline Study”: Pontine Glioma pipeline comprises of 24 drugs under development as of February 2018. Of these, 6 drugs are in Phase 1 and 3 drugs are in phase ...

... in user friendly manner offering quick access to Papillary Thyroid Cancer clinical trials. Major drugs under development in Papillary Thyroid Cancer are provided in the report along with their ...

... in user friendly manner offering quick access to Medullary Thyroid Cancer clinical trials. Major drugs under development in Medullary Thyroid Cancer are provided in the report along with their ...

... in user friendly manner offering quick access to Follicular Thyroid Cancer clinical trials. Major drugs under development in Follicular Thyroid Cancer are provided in the report along with their ...

... hypothyroidism. Secondary hypothyroidism- dysfunction of pituitary gland or hypothalamus Drugs- Levothyroxine (synthetic T4) is the most commonly prescribed drug Hypothyroidism clinical ... offering quick access to Hypothyroidism clinical trials. Major drugs under development in Hypothyroidism are provided in the ...

... is presented in user friendly manner offering quick access to Hypoparathyroidism clinical trials. Major drugs under development in Hypoparathyroidism are provided in the report along with their ...

... . The report focuses on drugs and therapies being evaluated for Hyperthyroidism treatment in active clinical development phases including phase 1, ... user friendly manner offering quick access to Hyperthyroidism clinical trials. Major drugs under development in Hyperthyroidism are provided in the report along ...